Health and Medical Articles from Your Favorite Personal AI-Powered Health Assistant.
Searching…
No articles match your search. Try a different word or ask your AI doctor.
What the FDA's Category System Actually Means for Peptides Not all unapproved substances occupy the same regulatory space. The FDA's bulk substances…
What Qsymia Is and How It Works Qsymia is a prescription combination medication that pairs low-dose phentermine, a stimulant that suppresses…
Why Older Adults Are Considering Wegovy Obesity rates among adults over 60 have risen steadily over the past two decades. For many older adults,…
What Makes Orforglipron Dosing Different From Other GLP-1 Options Most people familiar with GLP-1 receptor agonists picture a weekly injection pen or…
Real-time health answers powered by AI—because your health matters now.
Get a free consultationWhat Makes Retatrutide and Tirzepatide Mechanistically Different Understanding why a simple dose conversion table does not exist starts with…
How These Two Medications Work Differently Retatrutide and semaglutide both fall under the broad category of GLP-1 based therapies, but their…
What Makes Orforglipron Different From Injectable GLP-1s Orforglipron is an oral, non-peptide GLP-1 receptor agonist, which sets it apart from…
Understanding the Two Medications Before You Switch Orforglipron and dulaglutide both activate the GLP-1 receptor, but they are fundamentally…
What "Off-Label" Actually Means for a Drug Like Semaglutide When the FDA approves a medication, that approval covers specific conditions at specific…
What Orforglipron Is and How It Differs from Other GLP-1 Drugs Foundayo (orforglipron) represents a meaningful shift in how GLP-1 receptor agonist…
What Peptides Actually Are, and Where GLP-1s Fit In The phrase "peptides vs. GLP-1s" is common in wellness circles, but it frames the comparison in a…
Why Someone Might Switch From Retatrutide to Liraglutide Retatrutide is a triple agonist that simultaneously targets GIP, GLP-1, and glucagon…
Why Patients Consider Switching Between These Two GLP-1 Medications Orforglipron and semaglutide both target the same GLP-1 receptor in the body, but…
